期刊文献+

采用特异性探针药物法对双峰驼CYP1A酶体外活性的测定 被引量:1

Determination of in vitro activities of bactrian camel CYP1A enzyme by specific probe drug
原文传递
导出
摘要 为探究双峰驼CYP1A酶体外活性及其对外源性药物代谢的影响,首先采用差速离心法制备双峰驼肝微粒体,并优化其体外孵育体系,然后采用高效液相色谱紫外检测法测定双峰驼肝微粒体孵育体系中CYP1A酶特异性底物非那西丁的代谢产物对乙酰氨基酚的动态含量,并借助Origin Pro8.6软件计算CYP1A酶的动力学参数。结果表明,双峰驼肝微粒体具有良好的酶活性,其蛋白质含量为1.652mg/g±0.341mg/g。经优化后孵育体系的最适宜底物的质量浓度为200μg/mL,最佳肝微粒体的质量浓度为4.95mg/mL,最适宜孵育时间为30min。双峰驼CYP1A酶体外孵育体系的最大反应速度为0.224 6nmol/(min·mg)±0.041 8nmol/(min·mg),米氏常数为5.577 9μmol/L±0.634 2μmol/L,内在代谢清除率为0.080 4(mL·min)/mg±0.023 1(mL·min)/mg。结果表明,本试验通过借助特异性探针药物动力学特征的研究,成功检测了双峰驼CYP1A酶的体外代谢活性。 In order to explore the in vitro activities of bactrian camel CYP1 Aon drug metabolism,firstly the bactrian camel hepatic microsome was prepared by using differential centrifugation,and the incubation system was optimized.And then the specific substrate of CYP1 Aenzyme and its metabolites-phenacetin and 4-Acetamidophenol concentration in bactrian camel liver microsomal incubation system were determined by high performance liquid chromatography with UV method(HPLC-UV).Finally the kinetic parameters of CYP1 A were calculated by using Origin Pro8.6software.The results showed that bactrian camel liver microsome possess good activities,and their protein content is 1.652mg/g±0.341mg/g.The most suitable substrate concentration was 200μg/mL,the best liver microsome concentration was 4.95mg/mL,and the optimum incubation time was 30 min,respectively.Maximum velocity of bactrian camel CYP1 Aenzymes was 0.224 6nmol/(min·mg)±0.041 8nmol/(min·mg)in vitro incubation system,the Michaelis constant was 5.577 9μmol/L±0.634 2μmol/L,and the intrinsic metabolic clearance rate was0.080 4(mL·min)/mg±0.023 1(mL·min)/mg.In conclusion,the in vitro metabolic activities of bactrian camel CYP1 Aenzymes were successfully detected by studying the pharmacokinetic characteristics of specific probe drug.
出处 《中国兽医科学》 CAS CSCD 北大核心 2015年第11期1177-1183,共7页 Chinese Veterinary Science
基金 国家自然科学基金项目(31260623)
关键词 双峰驼 CYP1A酶体外活性 探针药物 酶动力学 bactrian camel in vitro activities of CYP1Aenzyme probe drug enzyme kinetics
  • 相关文献

参考文献18

  • 1NELSON D R,KOYMANS L,KAMATAKI T,et al.P450superfamily:update on new sequences,gene mapping,accession numbers and nomenclature[J].Pharmacogenetics,1996,6(1):1-42.
  • 2PORTER T D.Jud Coon:35years of P450research,a synopsis of P450history[J].Drug Metab Dispos,2004,32(1):1-6.
  • 3KIMURA Y,ITO H,OHNISHI R,et al.Inhibitory effects of polyphenols on human cytochrome P450 3A4and 2C9activity[J].Food Chem Toxicol,2010,48(1):429-435.
  • 4简暾昱,徐帆,廖春龙,徐贵丽.3种方法测定大鼠肝微粒体蛋白含量的比较[J].中国药师,2011,14(3):342-345. 被引量:15
  • 5ESTABROOK R W.A passion for P450s(rememberances of the early history of research on cytochrome P450)[J].Drug Metab Dispos,2003,31(12):1461-1473.
  • 6LU C,LI A P.Species comparison in P450induction:effects of dexamethasone,omeprazole,and rifampin on P450isoforms 1A and 3Ain primary cultured hepatocytes from man,SpragueDawley rat,minipig,and beagle dog[J].Chem Biol Interact,2001,134(3):271-281.
  • 7苏明威,辛华雯,李维亮,熊磊,余爱荣,李罄,王乃平.HPLC法测定CYP 3A4酶活性的研究[J].华南国防医学杂志,2009,23(5):53-56. 被引量:8
  • 8KARJALAINEN M J,NEUVONEN P J,BACKMAN J T.In vitroinhibition of CYP1A2by model inhibitors,anti-inflammatory analgesics and female sex steroids:predictability of in vivo interactions[J].Basic Clin Pharmacol Toxicol,2008,103(2):157-165.
  • 9CINTI D L,MOLDEUS P,SCHENKMAN J B.Kinetic parameters of drug-metabolizing enzymes in Ca2+-sedimented microsomes from rat liver[J].Biochem Pharmacol,1972,21(24):3249-3256.
  • 10王莉娥,杨明学,谢广云.一种用聚乙二醇制备微粒体的方法[J].生物化学与生物物理进展,1995,22(5):462-464. 被引量:19

二级参考文献36

  • 1张慧锋,王月鹏,李妍.细胞色素P450的研究进展[J].吉林医药学院学报,2005,26(3):174-177. 被引量:24
  • 2王莉娥,杨明学,谢广云.一种用聚乙二醇制备微粒体的方法[J].生物化学与生物物理进展,1995,22(5):462-464. 被引量:19
  • 3金科涛,王宇光,徐彭,高月.HPLC测定大鼠肝微粒体P450活性方法学研究进展[J].药物分析杂志,2006,26(3):415-419. 被引量:25
  • 4Cinti DL, Moldeus P, Schenkman JB. Kinetic parameters of drugmetabolizing enzymes in Ca2+sedimented microsomes from rat liver[J]. Biochem Pharmacol, 1972,21 (24) : 3249-3256.
  • 5鲁子贤,蛋白质和酶学研究方法.1,1989年
  • 6团体著者,生物化学,1978年
  • 7Nelson D R, Koymans L, Kamataki T, Stegeman J J, Feyereisen R, Waxman D J, Waterman M R, Gotoh O, Coon M J, Estabrook R W, Gunsalus I C, Nebert D W. P450 super family: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 1996, 6(1): 1-42.
  • 8Wrighton S A, Schuctz E C, Thummel K E, Shcn D D, Korzekwa K R, Warkins P B. The human CYP3A subfamily: practical considerations. Drug Metabolism Reviews, 2000, 32 (3/4): 339-361.
  • 9Jirimutu, Wang Z, Ding G H, Chen G L, Sun Y M, Sun Z H, Zhang H P, Wang L, Hasi S R, Zhang Y, Li J M, Shi Y X, Xu Z, He C, Yu S, Li S, Zhang W B, Batmunkh M, Ts B, Narenbam, Unierhu, Bat-Ireedui S, Gao H W, Baysgalan B, Li Q, Jia Z L, Turigenbayila, Subudenggerile, Narenmanduhu, Wang Z X, Wang J, Pan L, Chen Y C, Ganerdene Y, Dabxilt, Erdemt, Altansha, Altansukh, Liu T, Can M H, Aruuntsever, Bayart, Hosblig, He F, Zhati A, Zheng G Y, Qiu F, Sun Z, Zhan L L, 7_,hao W J, Liu B H, Li C, Chen Y Q, Tang X Y, Guo C Y, Liu W, Ming L, Temuulen, Cuil A, Li Y, Gao J H, Li J, Wurentandi, Niu S, Sun T, Zhai Z X, Zhang M, Chen C, Baldan T, Bayaer T, Li Y X, Meng H. Genome sequences of wild and domestic Bactrian camels. Nature Communications, 2012, 3:1202.
  • 10李筱曼.内源性氢化可的松代谢评价体内CYP3A活性研究[D].长沙:中南大学,2007.

共引文献42

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部